TWD 83.5
(2.2%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 1.34 Billion | 1.28 Billion | 302.1 Million | 973.6 Million | 1.61 Billion |
Cost of Revenue | 951.95 Million | 1.05 Billion | 281.35 Million | 624.95 Million | 1.08 Billion |
Gross Profit | 392.15 Million | 224.88 Million | 20.74 Million | 348.64 Million | 523.64 Million |
Operating Expenses | 206.24 Million | 254.52 Million | 129.65 Million | 179.54 Million | 247.04 Million |
Selling, General and Administrative Expenses | 206.57 Million | 209.31 Million | 129.64 Million | 178.86 Million | 247.04 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | -336 Thousand | 4.16 Million | 6.89 Million | 9.98 Million | - |
Cost and Expenses | 1.15 Billion | 1.31 Billion | 411.01 Million | 804.5 Million | 1.33 Billion |
Operating Income | 185.91 Million | -18.72 Million | -108.66 Million | 188.68 Million | 276.6 Million |
Interest Expense | 590 Thousand | 723 Thousand | 795 Thousand | 547 Thousand | 270 Thousand |
Income Tax Expense | 41.01 Million | 170 Thousand | -20.5 Million | 27.34 Million | 55.92 Million |
Earnings before Tax | 220.58 Million | 1.75 Million | -106.17 Million | 114.11 Million | 278.69 Million |
Net Income | 179.57 Million | 1.58 Million | -85.66 Million | 86.76 Million | 223.59 Million |
Earnings Per Share Basic | 5.93 | 0.05 | -2.81 | 2.96 | 7.87 |
Earnings Per Share Diluted | 5.93 | 0.05 | -2.81 | 2.96 | 7.86 |
Weighted Average Shares Outstanding | 30.28 Million | 30 Million | 30.46 Million | 29.25 Million | 28.41 Million |
Weighted Average Shares Outstanding (Diluted) | 30.3 Million | 30 Million | 30.46 Million | 29.29 Million | 28.46 Million |
Gross Margin | 0.29 | 0.18 | 0.07 | 0.36 | 0.32 |
EBIT Margin | 0.19 | 0.01 | -0.26 | 0.22 | 0.19 |
Profit Margin | 0.13 | 0.00 | -0.28 | 0.09 | 0.14 |
EBITDA | 251.03 Million | 32.1 Million | -74.15 Million | 217.03 Million | 311.4 Million |
Earnings Before Tax Margin | 0.14 | -0.01 | -0.36 | 0.19 | 0.17 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 342.51 Million | 632.74 Million | 411.6 Million | 1.34 Billion | 568.09 Million | 172.25 Million |
Cost of Revenue | 259.51 Million | 481.71 Million | 256.43 Million | 951.95 Million | 423.79 Million | 126.89 Million |
Gross Profit | 83 Million | 151.03 Million | 155.16 Million | 392.15 Million | 144.29 Million | 45.35 Million |
Operating Expenses | 41.71 Million | 62.18 Million | 53.46 Million | 206.24 Million | 70.93 Million | 42.5 Million |
Selling, General and Administrative Expenses | 41.71 Million | 62.18 Million | 53.46 Million | - | 71.28 Million | 42.5 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 219 Thousand | 517 Thousand | 103 Thousand | 817 Thousand | 130 Thousand | 237 Thousand |
Cost and Expenses | 301.23 Million | 543.9 Million | 309.9 Million | 1.15 Billion | 494.73 Million | 169.4 Million |
Operating Income | 40.1 Million | 91.7 Million | 100.12 Million | 190.11 Million | 77.86 Million | 4.5 Million |
Interest Expense | 70 Thousand | 112 Thousand | 140 Thousand | 590 Thousand | 125 Thousand | 147 Thousand |
Income Tax Expense | 10.32 Million | 18.32 Million | 20.21 Million | 41.01 Million | 16.59 Million | 2.47 Million |
Earnings before Tax | 34.37 Million | 91.59 Million | 100.86 Million | 220.58 Million | 81.03 Million | 9.52 Million |
Net Income | 24.05 Million | 73.26 Million | 80.64 Million | 179.57 Million | 64.43 Million | 7.05 Million |
Earnings Per Share Basic | 0.73 | 2.22 | 2.66 | - | 2.12 | 0.24 |
Earnings Per Share Diluted | 0.73 | 2.22 | 2.66 | - | 2.12 | 0.24 |
Weighted Average Shares Outstanding | 32.94 Million | 33 Million | 30.34 Million | 30.25 Million | 30.43 Million | 29.83 Million |
Weighted Average Shares Outstanding (Diluted) | 32.94 Million | 33 Million | 30.36 Million | 30.3 Million | 30.43 Million | 29.83 Million |
Gross Margin | 0.24 | 0.24 | 0.38 | 0.29 | 0.25 | 0.26 |
EBIT Margin | 0.14 | 0.16 | 0.26 | - | 0.15 | 0.07 |
Profit Margin | 0.07 | 0.12 | 0.20 | 0.13 | 0.11 | 0.04 |
EBITDA | 47.41 Million | 99.18 Million | 108.01 Million | - | 85.9 Million | 11.39 Million |
Earnings Before Tax Margin | 0.12 | 0.14 | 0.24 | 0.14 | 0.14 | 0.03 |
VOE
FIVE
PPLPHARMA
300888
ARMK
NNDNF